CymaxTM Human IL-6 ELISA Kit
- Known as:
- CymaxTM Human Interleukin-6 Enzyme-linked immunosorbent assay test Kit
- Catalog number:
- LF-EK0260
- Product Quantity:
- 1
- Category:
- Elisa Kits
- Supplier:
- Abfron
- Gene target:
- CymaxTM Human IL-6 ELISA Kit
Related genes to: CymaxTM Human IL-6 ELISA Kit
- Gene:
- CEBPB NIH gene
- Name:
- CCAAT enhancer binding protein beta
- Previous symbol:
- TCF5
- Synonyms:
- LAP, CRP2, NFIL6, IL6DBP, C/EBP-beta
- Chromosome:
- 20q13.13
- Locus Type:
- gene with protein product
- Date approved:
- 1991-02-27
- Date modifiied:
- 2018-02-23
- Gene:
- CEBPD NIH gene
- Name:
- CCAAT enhancer binding protein delta
- Previous symbol:
- -
- Synonyms:
- CRP3, CELF, C/EBP-delta, NF-IL6-beta
- Chromosome:
- 8q11.21
- Locus Type:
- gene with protein product
- Date approved:
- 1992-06-24
- Date modifiied:
- 2018-02-23
- Gene:
- ENTPD6 NIH gene
- Name:
- ectonucleoside triphosphate diphosphohydrolase 6
- Previous symbol:
- CD39L2, IL6ST2
- Synonyms:
- NTPDase-6, dJ738P15.3
- Chromosome:
- 20p11.21
- Locus Type:
- gene with protein product
- Date approved:
- 1998-03-20
- Date modifiied:
- 2019-02-28
- Gene:
- IL6 NIH gene
- Name:
- interleukin 6
- Previous symbol:
- IFNB2
- Synonyms:
- IL-6, BSF2, HGF, HSF
- Chromosome:
- 7p15.3
- Locus Type:
- gene with protein product
- Date approved:
- 1986-01-01
- Date modifiied:
- 2017-07-12
- Gene:
- IL6RP1 NIH gene
- Name:
- interleukin 6 receptor pseudogene 1
- Previous symbol:
- IL6RL1
- Synonyms:
- -
- Chromosome:
- 9q22.2
- Locus Type:
- pseudogene
- Date approved:
- 1991-08-18
- Date modifiied:
- 2014-11-19
Related products to: CymaxTM Human IL-6 ELISA Kit
Related articles to: CymaxTM Human IL-6 ELISA Kit
- Gestational diabetes mellitus (GDM) is a common metabolic complication of pregnancy associated with adverse maternal and fetal outcomes. Nevertheless, the molecular mechanism of placental dysfunction in GDM are still not clear, especially the role of ferroptosis and its interplay with oxidative stress, inflammation, and angiogenesis. - Source: PubMed
Monisha SMilan K LAnuradha MRamkumar K M - To investigate the six-degree-of-freedom (6-DOF) kinematic characteristics of the knee joint and changes in plasma inflammatory factors during the acute and non-acute phases following anterior cruciate ligament (ACL) injury, thereby providing clinical evidence for the necessity of early intervention after ACL injury. - Source: PubMed
Wei XinyiZhang YixinXue ShiyuanSun YuerongQi ChaoFu Haitao - Epidermal stem cell (ESC) degeneration is closely associated with skin aging and functional deterioration. Type XVII collagen (COL17A1) critically regulates ESC polarity and epidermal homeostasis. This study investigated the protective effects of recombinant human COLXVII (rhCol17) against blue light-induced photoaging, particularly on ESC. - Source: PubMed
Publication date: 2026/07/16
Wang XudongLi QiangYang XinBai YuSui ShijiaGe GeLi HaitaoYang Rongya - Breast cancer remains the most common malignancy among women worldwide. Despite advances in screening and treatment that have improved five-year survival, patients often experience weight gain, reduced cardiorespiratory fitness, metabolic disturbances, and impaired quality of life during or after therapy. Moderate‑intensity continuous training (MICT) is effective but time‑consuming, while high‑intensity interval training (HIIT) offers a time‑efficient alternative that may provide greater cardiopulmonary stimulation. However, evidence on its effects on body composition, quality of life, and inflammatory markers in breast cancer patients remains inconclusive. - Source: PubMed
Publication date: 2026/07/16
Zheng JieYan RuiZhou ShuhangLin Jiale - Gut microbiota dysbiosis is increasingly viewed as a disruption of microbial metabolic functions rather than only a shift in microbial composition. Microbiota-derived metabolites not only shape microbial ecology but also directly influence surrounding host tissues by modulating epithelial cell signaling, inflammation, and tumor-associated processes. Among dysbiosis-associated microbes, Fusobacterium is consistently enriched in colorectal cancer (CRC) and contributes to tumor progression, yet the ecological factors regulating its expansion and interaction with host tissues remain unclear. Here, we investigated how microbiome-derived metabolite environments associated with healthy and dysbiotic microbial communities influence Fusobacterium fitness and colorectal epithelial cell behavior. - Source: PubMed
Publication date: 2026/07/16
Dhiman ChhaviKumar AbhiramSonak Shreya SErukulla PriyankaNimbarte Vijaykumar DayaramNarayan Kumar Pranav